[FDA-labelled indication?[1]] No [TGA-labelled indication?[3]] No [MHRA-labelled indication?[11]] No [Literature support] Two clinical trials have confirmed its efficacy in this indication as both a monotherapy and as an adjunct to tretinoin.[79][80][81] [Indications] 
Acute myeloid leukaemia